The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehlers, S.
Right arrow Articles by Pfeffer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehlers, S.
Right arrow Articles by Pfeffer, K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Tuberculosis
The Journal of Immunology, 2000, 165: 483-492.
Copyright © 2000 by The American Association of Immunologists

Lethal Granuloma Disintegration in Mycobacteria-Infected TNFRp55-/- Mice Is Dependent on T Cells and IL-121

Stefan Ehlers2,*, Stefanie Kutsch*, Eva M. Ehlers{dagger}, Jochen Benini* and Klaus Pfeffer{ddagger}

* Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany; {dagger} Department of Anatomy, Medical University of Lübeck, Lübeck, Germany; and {ddagger} Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Genetically susceptible, TNFRp55 gene-deficient (TNFRp55-/-) mice succumb to infection with Mycobacterium avium. Before their death, M. avium-infected TNFRp55-/- mice develop granulomatous lesions that, in contrast to granulomas in wild-type syngeneic mice, undergo acute disintegration. To determine the factors involved in these events, we depleted T cell subsets or neutralized the inflammatory cytokines IFN-{gamma}, IL-12, or TNF in TNFRp55-/- mice infected i.v. with M. avium. Infected TNFRp55-/- mice treated with a control mAb became moribund between days 26 and 34 postinfection, showing widespread inflammatory cell apoptosis within disintegrating granulomas. In contrast, TNFRp55-/- mice depleted of either CD4+ or CD8+ cells after granuloma initiation stayed healthy until at least day 38 postinfection and showed no signs of granuloma destruction. Neutralization of IL-12, but not of IFN-{gamma} or TNF, also protected M. avium-infected TNFRp55-/- mice from granuloma decomposition and from premature death. Treatment with dexamethasone or with a specific inhibitor of inducible NO synthase did not prevent granuloma dissolution or death of TNFRp55-/- mice. In conclusion, granuloma disintegration in TNFRp55-/- mice is a lethal event that is dependent on IL-12 and that is mediated by an excess of T cells.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Granulomas are formed as a consequence of chronically persisting Ag and are thus a hallmark of all mycobacterial infections. Granulomas provide for a highly ordered juxtaposition of macrophages and T cells in such a way that antimycobacterial mechanisms may be effectively coordinated and regulated (1). On the other hand, granulomas displace and destroy parenchymal tissue, thereby determining the extent of organ pathology and, ultimately, the outcome of mycobacterial disease (2, 3).

The integrity of a developing granuloma is crucial in terms of disease progression and survival. For example, treatment of mice with an anti-TNF antiserum during the chronic stage of infection with Mycobacterium bovis bacillus Calmette-Guérin resulted in granuloma dissolution and extensive bacterial proliferation (4), and mice deficient in some aspect of organized mononuclear cell recruitment, such as SCID, IFN-{gamma}-knockout, or TNF-knockout mice, readily succumbed to infection with Mycobacterium tuberculosis (5, 6, 7). In particular, the disintegration of the granuloma structure in the form of caseous necrosis and rupturing of the cavity into a bronchus is characteristic of advanced human tuberculosis (2, 3). The cellular and molecular mechanisms involved in this process have largely defied definition because of the lack of a mouse model of infection that adequately reflects the full spectrum of the immunopathology evident in humans.

Experimental infection in mice with Mycobacterium avium, the causative agent of the most prevalent opportunistic infection in AIDS patients, is particularly well-suited to the study of granuloma induction, maintenance, and necrosis. After i.v. infection with M. avium, mice develop persistent granulomatous lesions in all infected organs (8, 9, 10, 11). Aerogenic infection with highly virulent M. avium strains induces a pulmonary pathology remarkably similar to that found in human tuberculosis (12).

Exploiting the M. avium model for the study of factors involved in the formation and maintenance of granulomas, we previously showed that granuloma development was significantly delayed in mice deficient for the TNFRp55 (13). Although these mice had similar bacterial counts in infected organs compared with immunocompetent mice, M. avium-infected TNFRp55-/- mice all succumbed to infection. Before death, granulomatous lesions in TNFRp55-/- mice acutely disintegrated, showing widespread inflammatory cell apoptosis and necrosis of both granulomatous and surrounding parenchymal tissues. Furthermore, significantly increased numbers of CD3+ cells within disintegrating lesions of TNFRp55-/- mice were found, and higher levels of the proinflammatory mediators IFN-{gamma}, IL-12p40, and TNF were detected in organ homogenates of M. avium-infected TNFRp55-/- mice (12, 13).

It remained unknown whether T cells and/or the mentioned key inflammatory mediators were causally involved in both the death and the granuloma disintegration occurring in TNFRp55-/- mice in the course of M. avium infection. Therefore, we selectively depleted T cell subpopulations or neutralized proinflammatory mediators in M. avium-infected TNFRp55-/- mice and investigated the effect of these treatments on survival, bacterial containment, and histopathology. Our results show that both granuloma disintegration and death of TNFRp55-/- mice infected with M. avium are dependent on T cells and IL-12.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

The bcg-susceptible TNFRp55-/- mice used in these studies are fifth generation backcrosses of the original TNFRp55-deficient 129Sv strain (14) onto C57BL/6 mice. TNFRp55-/- and syngeneic C57BL/6 TNFRp55+/+ mice were raised in the animal breeding facilities of Charles River Wiga (Sulzfeld, Germany). TNFRp55-/- mice on a 129Sv background (15) were originally obtained from The Jackson Laboratory (Bar Harbor, ME) and were the kind gift of Dr. U. Steinhoff (Max-Planck-Institute of Infection Biology, Berlin, Germany). All mice were serologically found to be free of Abs to the most common viral and bacterial mouse pathogens. Mice were used when they were 8–12 wk old. During the course of M. avium infection, age- and sex-matched groups of four to five mice per experimental group were housed in isolator cages under barrier conditions in the animal facilities at the Borstel Research Center.

Bacteria

M. avium, strain TMC724 (originally obtained from Dr. F. Collins, Trudeau Institute, Saranac Lake, NY), was passaged in C57BL/6 mice twice and cultured in Middlebrook 7H9 (Difco, Detroit, MI) medium supplemented with OADC (oleic acid, albumin, dextrose, catalase; Becton Dickinson, Heidelberg, Germany) to a mid-logarithmic phase. Aliquots were frozen at -70°C until they were needed. An inoculum of bacteria was prepared by thawing an aliquot and diluting it in PBS. Groups of five mice per experimental variable were infected i.v. via a lateral tail vein with indicated inocula in 0.2 ml PBS. Mice were scored as moribund and sacrificed when weight loss exceeded 25% of the body weight at the beginning of infection. Mice were anaesthetized and killed at indicated time points to determine bacterial CFU in infected organs. Organs were removed aseptically and homogenized in 10 ml distilled water to determine bacterial loads by plating serial 10-fold dilutions of whole organ homogenates on nutrient Middlebrook 7H10 agar (Difco) supplemented with OADC. Bacterial colony numbers (CFU) were determined after 14–21 days incubation at 37°C in humidified air. Data are shown as mean log10 CFU counts ± SD. The natural course of infection and the kinetics of granuloma formation and disintegration in immunocompetent and TNFRp55-/- mice infected with these strains were previously described (11, 13). All animal experiments were approved by the local ethics committee instituted by the Ministry of Nature, Environment and Forestation (Kiel, Germany).

Reagents

The following mAbs (specificities in parentheses) were used for in vivo studies: GK1.5 (anti-CD4), 2.43 (anti-CD8), 23/7 (irrelevant epitope), XMG1.2 (anti-IFN-{gamma}, kindly provided by Dr. A. O’Garra from the DNAX Research Institute, San Diego, CA), and C 15.1 and C 15.6 (both anti-IL-12p40, kindly provided by the Wistar Institute, Philadelphia, PA). Abs were purified by ammonium sulfate precipitation and subsequent dialysis of crude ascites produced in nude mice by Dr. Rui Appelberg (Instituto de Biología Molecular e Celular, Porto, Portugal). The anti-TNF mAb TN3-19.12 was a kind gift from Dr. R. Schreiber (Washington University School of Medicine, St. Louis, MO). The hamster anti-IFN-{gamma} mAb (H22) was purchased from Genzyme (Rüsselsheim, Germany). Hamster control IgG was from Dianova (Hamburg, Germany). For immunohistochemistry, the mAbs KT174 (anti-CD4) and KT15 (anti-CD8{alpha}; BioSource International, Camarillo, CA) or a rabbit antiserum specific for the proliferation-associated Ag Ki-67 (16) were used. Secondary (rabbit anti-rat IgG) and tertiary Abs (goat anti-rabbit IgG and donkey anti-goat IgG) were from Dianova. L-N6-imino-ethyl-lysine (L-NIL)3 was purchased from Alexis (Läufelfingen, Switzerland) and dissolved in water (adjusted to pH 2.7 to prevent microbial growth). Dexamethasone (Fortecortin Mono 8) was from Merck (Darmstadt, Germany).

Treatment protocols

For T cell subset depletion, groups of five mice each were injected i.p. with 500 µg of the specific mAb in a volume of 500 µl PBS once weekly. This depletion protocol was previously shown to result in >95% depletion of the targeted T cell subset when assessed by FACS analysis of spleen cells (17). For cytokine neutralization, the following Ab concentrations were used: 2 mg/500 µl anti-IFN-{gamma} (XMG 1.2), 300 µg/500 µl anti-IFN-{gamma} (H22), 250 µg/500 µl anti-TNF, and anti-IL-12p40 (mixture of 1 mg C15.1 and 1 mg C15.6 in 500 µl). The concentrations of the anti-cytokine Abs used were previously shown to be neutralizing in vivo (9, 18, 19). Treatment was by once weekly i.p. injection of purified Abs and was initiated after granulomas were established because depletion at the beginning of infection was previously demonstrated to significantly delay granuloma development (11, 18). All depletion studies were repeated at least once and gave qualitatively identical results, although the kinetics of granuloma disintegration differed slightly between experiments.

Fresh acidified drinking water with or without 5 mM L-NIL was provided to the mice every other day. A toxicity study previously demonstrated that 5 mM L-NIL does not influence water or food intake or impair weight gain in naive mice (20) but that it is fully capable of reducing nitrate/nitrite levels in M. avium- or M. tuberculosis-infected mice to the levels of uninfected controls (21). Dexamethasone was used at 0.4 mg in 100 µl PBS and was injected s.c. at the base of the tail every other day.

Histology

One cranial and one caudal liver lobe per mouse were fixed in 4% formaline-PBS, set in paraffin blocks, sectioned (2–3 µm), and stained using hematoxylin and eosin. In the figure legends, the original magnification of the photographic image is indicated.

Immunohistology

For the detection of CD4+ cells or CD8+ cells, frozen tissue sections were prepared using a cryostat (Frigocut E 2800; Leica, Bensheim, Germany). Four-micrometer sections were air-dried and fixed in acetone before storage at -70°C. After acetone-chloroform treatment, sections were blocked with 0.3% superoxide and incubated with mAb KT174 (anti-CD4) or KT15 (anti-CD8{alpha}). Appropriately diluted rabbit anti-rat IgG was used as a secondary Ab, and goat anti-rabbit IgG peroxidase was used as a tertiary Ab. For the detection of proliferating cells, a rabbit anti-mouse Ki-67 antiserum was used (16) with goat anti-rabbit IgG and donkey anti-goat IgG peroxidase as secondary Abs. Development was performed with 3–3'-diaminobenzidine (Sigma, Deisenhofen, Germany) and urea superoxide (Sigma), and hemalum was used to counterstain the slides. The number of granuloma-associated cells positive for a specific marker was determined by counting them in three randomly chosen 40x microscopic fields in five nonsequential liver sections per mouse (four mice per group). Data represent the means of 60 determinations ± SD.

Electron microscopy

Perfusion fixation of the liver was performed at room temperature via the vena portae with 2% glutaraldehyde/0.6% paraformaldehyde in a 0.06 M sodium cacodylate buffer (pH 7.35) for 10 min. Livers were immersed in the fixative for 72 h at 4°C, rinsed in 0.2 M sodium cacodylate buffer (pH 7.35), and postfixed with 1% osmium tetroxide in the same buffer for 2 h at room temperature. After rinsing in 2.4% sodium chloride solution, the samples were washed in 0.2 M sodium acetate buffer (pH 5.0) and block stained with 1% uranyl acetate in 0.2 M sodium acetate buffer in the dark for 30 min. After dehydration in alcohol and embedding in araldite, semithin sections (0.5 µm) were prepared and stained with azure II-methylene blue. Ultrathin sections (60 nm) were stained with lead citrate and examined in a Philips 400 electron microscope.

Cytokine ELISAs and determination of liver enzyme levels

Plasma was obtained after centrifugation of heparinized blood drawn from the posterior vena cava of anesthetized mice and stored at -70°C until further use. ELISA measurements of TNF, IL-12p40, and IFN-{gamma} levels in the plasma were conducted as stipulated by the manufacturer (R&D Systems, Wiesbaden, Germany). Levels of alanine serine aminotransferase (ASAT) and lactate dehydrogenase (LDH) were measured in the plasma of mice using standard procedures and an automated sample analyzer in the laboratory of clinical biochemistry of the Borstel Clinical Center.

Statistics

Quantifiable data are expressed as the means of individual determinations ± SD. Statistical analysis was performed using Student’s t test, or the Welch test in case of unequal variances.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of T cell subset depletion on the survival of M. avium-infected TNFRp55-/- mice

The course of bacterial replication and delayed granuloma formation in M. avium-infected TNFRp55-/- mice was previously described in detail (13). TNFRp55+/+ mice infected with 106 CFU M. avium TMC724 initiated granuloma formation between days 10 and 15 postinfection, whereas similarly infected TNFRp55-/- mice developed granulomatous lesions with a delay of ~5–8 days. Mononuclear cell infiltrations were more diffuse in TNFRp55-/- mice, had a higher cellularity in relation to their smaller size, and lacked the appearance of mature granulomas because they contained fewer epithelioid macrophages. With an inoculum of 106 CFU M. avium, granuloma disintegration in TNFRp55-/- mice reproducibly occurred during the fifth week postinfection, and infected TNFRp55-/- mice succumbed to infection before day 35.

When examined by immunohistochemistry at day 21 postinfection, T cell numbers in incipient lesions of TNFRp55-/- mice were similar to those found in the granulomas of TNFRp55+/+ mice (Ref. 13 and data not shown). However, when the amount of CD4+ and CD8+ T cells in disintegrating granulomatous lesions of TNFRp55-/- mice were compared with those present in epithelioid granulomas in TNFRp55+/+ mice at day 33 postinfection (Fig. 1Go), a significant increase in both subsets was evident (59 ± 16 vs 20 ± 7 granuloma-associated CD4+ cells and 77 ± 11 vs 15 ± 4 granuloma-associated CD8+ cells per 400x microscopic field; p < 0.01). The staining pattern for the proliferation-associated Ag Ki-67 showed a similar distribution as the staining pattern for these lymphocyte markers, and the number of proliferating Ki-67+ cells was also significantly increased in lesions of TNFRp55-/- mice at day 33 postinfection (Fig. 1Go).



View larger version (206K):
[in this window]
[in a new window]
 
FIGURE 1. Increased accumulation of CD4+ and CD8+ cells in M. avium-infected TNFRp55-/- mice. TNFRp55+/+ (a, c, and e) and TNFRp55-/- (b, d, and f) mice were i.v. infected with 106 CFU M. avium and sacrificed on day 33 of infection. Liver sections were stained with anti-CD4 (a and b) or anti-CD8 (c and d) mAbs (hematoxylin and eosin; magnification x64), or with an anti-Ki67-antiserum (e and f; immunoperoxidase stain; magnification x128).

 
To evaluate whether T cells were involved and, subsequently, which T cell subset was involved in granuloma disintegration, groups of five TNFRp55-/- mice were infected with 106 CFU M. avium and treated with 0.5 mg of anti-CD4, anti-CD8, or control mAb on days 23 and 30 of infection, i.e., subsequent to granuloma establishment. Depletion efficacy was assessed by immunohistology of the liver with Abs recognizing a different epitope. Anti-CD4 treatment resulted in depletion of more than 95% of CD4+ cells, and anti-CD8 treatment depleted ~90–95% of CD8+ cells (data not shown).

All TNFRp55-/- mice that had received control mAbs became moribund between days 26 and 30 of infection (Fig. 2Go). In contrast, TNFRp55-/- mice that had received either anti-CD4 or anti-CD8 mAbs appeared completely healthy until day 38, when all treated TNFRp55-/- mice were sacrificed to compare the lesions of treated surviving mice with the lesions of control mAb-treated moribund mice. TNFRp55-/- mice receiving three injections (on days 24, 31, and 38 postinfection) of both anti-CD4 and anti-CD8 mAbs remained completely healthy until day 45, when the experiment was terminated (Fig. 2Go). Thus, depletion of T cell subsets significantly prolonged survival of TNFRp55-/- mice infected with M. avium.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 2. Survival of M. avium-infected TNFRp55-/- mice treated with anti-CD4 and/or anti-CD8 mAb. TNFRp55-/- mice were i.v. infected with 106 CFU M. avium and treated with i.p. injections of indicated mAbs on days 23, 30, and 38 postinfection. Data indicate the percentage of mice surviving per group (five mice per group) in the course of M. avium infection. Data are from one experiment of three, which gave qualitatively identical results.

 
In the next step, bacterial loads in the livers, spleens, and lungs were compared between moribund control mAb-treated TNFRp55-/- mice and T cell subset-depleted TNFRp55-/- mice (Fig. 3Go). There was no significant difference between groups in any of the organs tested. Thus, depletion of T cell subsets, which prolonged survival in TNFRp55-/- mice, did not affect bacterial loads in the time frame studied, indicating that death of TNFRp55-/- mice did not correlate with bacterial burden.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 3. Bacterial load in the livers of M. avium-infected mice. Mice were i.v. infected with 106 CFU M. avium, treated with i.p. injections of indicated mAbs on days 23 and 30 postinfection, and sacrificed when moribund or on day 38 of infection. Column 1, C57BL/6 TNFRp55+/+ mice, untreated; column 2, C57BL/6 TNFRp55-/- mice, treated with control mAbs;column 3, C57BL/6 TNFRp55-/- mice, treated with anti-CD4 mAbs; column 4, C57BL/6 TNFRp55-/- mice, treated with anti-CD8 mAbs; column 5, 129Sv TNFRp55-/- mice, untreated. *, p < 0.01 if compared with column 1. Data represent the means ± SD of the log10 CFU in the livers of five mice per group. Data shown are from one experiment of two performed, which gave almost identical results.

 
Effect of T cell subset depletion on granuloma structure in M. avium-infected TNFRp55-/- mice

Liver histology was examined in moribund TNFRp55-/- mice treated with control mAbs and was compared with anti-CD4- or anti-CD8-treated TNFRp55-/- mice sacrificed at day 38 postinfection. Conventional and electron microscopy was performed (Fig. 4Go). Control mAb-treated TNFRp55-/- mice showed massive granuloma disintegration with the characteristic hallmarks of wide-spread apoptotic cell death. Among these apoptotic cells, many macrophages could be identified by the presence of engulfed mycobacteria. In contrast, T cell subset-depleted TNFRp55-/- mice had almost normal granuloma development, showing incipient epithelioid cell differentiation and lacking signs of inflammatory cell apoptosis. In addition, granuloma integrity was fully maintained until day 45 in those TNFRp55-/- mice that had been treated with three injections (on days 24, 31, and 38 postinfection) of the combination of anti-CD4 and anti-CD8 mAbs.



View larger version (142K):
[in this window]
[in a new window]
 
FIGURE 4. Histopathology and electron microscopy of lesions in the livers of M. avium-infected mice. For experimental procedures, see Fig. 3Go. a and c, Well-organized granulomas in TNFRp55+/+ mice composed of epithelioid cells with large, round nuclei and granular endoplasmatic reticulum (open arrow) and mycobacteria in phagocytic vacuoles (filled arrow). b and d, Poorly organized, disintegrating granulomas in TNFRp55-/- mice showing numerous apoptotic cells with fragmented nuclei containing condensed chromatin and apoptotic bodies (filled arrows). e and g, Well-defined granulomas in TNFRp55-/- mice depleted of CD4+ T cells. Granulomas contain epithelioid cells with round nuclei and granular endoplasmic reticulum (open arrow). Filled arrow indicates mycobacteria within phagocytic vacuoles. f and h, Well-structured granulomas in TNFRp55-/- mice depleted of CD8+ T cells. Granulomas contain epithelioid cells with round nuclei and granular endoplasmic reticulum (open arrow). a, b, e, and f, Hematoxylin and eosin stain (magnification x64). c, d, g, and h, Electron micrographs (magnification x2800).

 
Adjacent to disintegrating granulomas in control mAb-treated TNFRp55-/- mice, liver cell necrosis was evident. In accordance with this finding, TNFRp55-/- mice treated with control mAb had dramatically increased ASAT and LDH serum levels. In comparison, liver enzyme levels in T cell subset-depleted TNFRp55-/- mice did not significantly differ from those seen in C57BL/6 TNFRp55+/+ mice (Table IGo). Thus, prolonged survival of TNFRp55-/- mice correlated with granuloma and tissue integrity, and T cells were the major mediators of host-damaging processes in infected TNFRp55-/- mice.


View this table:
[in this window]
[in a new window]
 
Table I. Enzyme levels in the sera of M. avium-infected mice1

 
To further substantiate this finding, two additional experiments were performed. First, we infected TNFRp55-/- 129Sv mice with 106 CFU M. avium. These mice carry the resistant allele of the natural resistance associated macrophage protein (Nramp1) gene and are known to develop few T cell responses to intracellular infections (22, 23). These mice indeed showed a remarkable innate capacity to inhibit proliferation of the highly virulent strain TMC724 (Fig. 3Go) and developed only small granulomatous lesions when examined at days 38 and 56 of M. avium infection. No granuloma destruction was evident in these mice during the entire observation period (up to 84 days), and ASAT and LDH levels were comparable to immunocompetent control-infected mice sacrificed at the same time (Table IGo).

Second, SCID mice deficient in T and B cells were infected with M. avium TMC724 and were treated with a neutralizing anti-TNF mAb starting on day 35 (i.e., subsequent to the delayed granuloma initiation in these mice; Ref. 18) for up to 5 wk. These mice did not show any signs of granuloma dissolution, further substantiating our interpretation that T cells are critically involved in granuloma disintegration.

Effect of cytokine neutralization on the survival of M. avium-infected TNFRp55-/- mice

To analyze the effect of T cell subset depletion on the levels of proinflammatory cytokines, the amounts of IL-12p40, TNF, and IFN-{gamma} were determined in the sera of infected mice (Fig. 5Go). IL-12p40 levels were somewhat increased in infected TNFRp55-/- mice when compared with infected TNFRp55+/+ mice. However, T cell subset depletion had no profound effect on IL-12p40 detectable in the sera of infected TNFRp55-/- mice. IFN-{gamma} and TNF amounts were markedly elevated in infected TNFRp55-/- mice when compared with infected TNFRp55+/+ mice. Treatment of infected TNFRp55-/- mice with anti-CD4 or anti-CD8 mAbs reduced the levels of IFN-{gamma} and TNF to the levels found in M. avium-infected TNFRp55+/+ mice (Fig. 5Go).



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 5. Cytokine levels in the sera of M. avium-infected mice. For experimental procedures, refer to Fig. 3Go. A, IL-12p40; B, TNF; C, IFN-{gamma}. Column 1, TNFRp55+/+ mice, untreated. Column 2, TNFRp55-/- mice, treated with control mAbs. Column 3, TNFRp55-/- mice, treated with anti-CD4 mAbs; *, p < 0.01 if compared with column 2 (B and C). Column 4, TNFRp55-/- mice, treated with anti-CD8 mAbs; *, p < 0.01 if compared with column 2 (B and C). Data are the means ± SD of five determinations per group. Data shown are from one experiment of two performed, which gave almost identical results.

 
To establish whether any of these mediators were causally involved in the granuloma disintegration observed in M. avium-infected TNFRp55-/- mice, each cytokine was neutralized by i.p. injection of neutralizing doses of specific mAbs on days 25 and 32 postinfection, i.e., subsequent to granuloma establishment. Starting on day 25 postinfection, an additional group of infected TNFRp55-/- mice was s.c. treated every other day with 0.4 mg dexamethasone as a nonspecific inhibitor of inflammation.

Neutralization of TNF or IFN-{gamma}, as well as treatment with dexamethasone, failed to increase survival times of infected TNFRp55-/- mice. All TNFRp55-/- mice thus treated died before day 37, which is similar to the results obtained with control mAb-treated TNFRp55-/- mice (Fig. 6Go). In contrast, mice treated for 2 wk with a combination of two mAbs specific for IL-12p40 survived until day 38 when they were sacrificed to compare their liver histopathology with that of moribund control mAb-treated TNFRp55-/- mice. Infected TNFRp55-/- mice receiving three injections of the anti-IL-12p40 mAbs (on days 24, 31, and 38 postinfection) remained completely healthy until the experiment was terminated on day 45 (Fig. 6Go). Thus, survival of M. avium-infected TNFRp55-/- mice was markedly prolonged by effective neutralization of IL-12.



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 6. Survival of M. avium-infected TNFRp55-/- mice treated with cytokine-neutralizing mAbs. TNFRp55-/- mice were infected with 106 CFU M. avium and treated with i.p. injections of the indicated neutralizing mAbs on days 25 and 32 postinfection or with s.c. injections of dexamethasone every other day after day 25 postinfection. Data represent the percentage of surviving mice per group in the course of M. avium infection (four to five mice per group; eight mice in the control mAb-treated group). Data are from one experiment of two, which gave qualitatively identical results.

 
Again, CFU counts in the treatment groups were compared. Dexamethasone treatment resulted in a significant increase in bacterial CFU counts in the liver, but all other groups showed practically identical, very high bacterial loads in the liver and spleen (Fig. 7Go). Therefore, survival did not correlate with different bacterial organ loads in the different mouse groups.



View larger version (11K):
[in this window]
[in a new window]
 
FIGURE 7. Bacterial load in the livers of M. avium-infected TNFRp55-/- mice treated with cytokine-neutralizing Abs. Mice were infected with 106 CFU M. avium, treated with i.p. injections of the indicated neutralizing mAbs on days 25 and 32 postinfection, and sacrificed when moribund or on day 38 postinfection. Column 1, TNFRp55-/- mice, treated with control mAbs; column 2, TNFRp55-/- mice, treated with anti-IL-12p40 mAbs; column 3, TNFRp55-/- mice, treated with anti-IFN-{gamma} mAb; column 4, TNFRp55-/- mice, treated with anti-TNF mAb; column 5, TNFRp55-/- mice, treated with dexamethasone. *, p < 0.05 if compared with column 1. Data represent the means ± SD of the log10 CFU in the livers of four to five mice per group. Data shown are from one experiment of two performed, which gave almost identical results.

 
Effect of cytokine neutralization on liver histology of M. avium-infected TNFRp55-/- mice

Histopathological examination revealed that anti-IL-12p40-treated TNFRp55-/- mice had compact granulomas showing epithelioid cell differentiation, whereas immature granulomatous lesions in TNFRp55-/- mice treated with anti-IFN-{gamma}, anti-TNF, or control mAb had completely disintegrated and were again characterized by an abundance of apoptotic cells (Fig. 8Go). Granulomas in infected, dexamethasone-treated moribund TNFRp55-/- mice were completely necrotic, whereas the surrounding liver tissue appeared less affected.



View larger version (129K):
[in this window]
[in a new window]
 
FIGURE 8. Liver histopathology in M. avium-infected TNFRp55-/- mice treated with cytokine-neutralizing Abs. For experimental procedures, see Fig. 7Go. a, TNFRp55-/- mice, treated with control mAbs. Disintegrating and necrotizing granulomatous lesions. b, TNFRp55-/- mice, treated with anti-IL-12p40 mAbs. Well-structured granulomas with epithelioid macrophages. c, TNFRp55-/- mice, treated with anti-IFN-{gamma} mAb. Disintegrating lesions with numerous apoptotic cells. Livers of TNFRp55-/- mice treated with anti-TNF mAb looked identical. d, TNFRp55-/- mice, treated with dexamethasone. Hematoxylin and eosin stain; magnification x64. Arrows indicate apoptotic cells. X, Necrotic areas.

 
Immunohistological analysis showed that fewer CD3+ cells accumulated in differentiating granulomatous lesions of anti-IL12p40-treated TNFRp55-/- mice than in disintegrating lesions of control mAb-treated TNFRp55-/- mice. Decreased recruitment after anti-IL-12p40 treatment was particularly pronounced for CD8+ cells and at day 45 postinfection.

The extent of granuloma disintegration and subsequent tissue necrosis in the different groups was quantitated using ASAT and LDH levels in the sera of mice. Only anti-IL-12p40-treated mice had low ASAT and LDH levels, results similar to those of infected TNFRp55+/+ controls, whereas infected control mAb-treated TNFRp55-/- mice or infected mice which had received anti-IFN-{gamma} had high levels of ASAT and LDH (Table IIGo). TNFRp55-/- mice treated with anti-TNF or dexamethasone also showed reduced ASAT and LDH levels compared with those of untreated TNFRp55-/- mice; however, ASAT and LDH levels were still markedly elevated compared with those of TNFRp55-/- mice treated with the anti-IL-12p40 mAbs (Table IIGo).


View this table:
[in this window]
[in a new window]
 
Table II. Enzyme levels in the sera of M. avium-infected TNFRp55-/- mice treated with cytokine-neutralizing Abs1

 
In conclusion, prolonged survival of M. avium-infected anti-IL-12p40-treated TNFRp55-/- mice correlated with maintained granuloma integrity, whereas granuloma disintegration proceeded unaltered in infected TNFRp55-/- mice treated with anti-TNF or anti-IFN-{gamma} and was always followed by premature death.

Because the inducible form of NO synthase (iNOS) was previously shown to be up-regulated in M. avium-induced granulomas (13, 21), the possibility was considered that NO might be responsible for the tissue damage in infected TNFRp55-/- mice. Therefore, TNFRp55-/- mice were infected and treated with the selective inhibitor of iNOS, L-NIL. However, L-NIL-treated TNFRp55-/- mice did not survive longer than untreated infected TNFRp55-/- mice, and granulomas of L-NIL-treated mice disintegrated with the characteristic histomorphology also evident in infected TNFRp55-/- mice left untreated. In accordance, ASAT and LDH serum levels were similarly high in both groups of mice.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The outcome of mycobacterial diseases is intrinsically linked to granuloma formation and maintenance of granuloma integrity (2, 3, 24). Using i.v. infection with M. avium in the mouse as a model system to study the factors governing granuloma integrity, we have previously established that a lack of TNFRp55 signaling results in a disregulated granulomatous response, namely granuloma disintegration and tissue necrosis (12, 13). We now demonstrate that T cells and IL-12 are crucially involved in inflammatory cell apoptosis and granuloma decomposition in M. avium-infected TNFRp55-/- mice. In fact, prevention of granuloma disintegration by neutralizing IL-12 or depleting T cell subsets significantly prolonged survival of M. avium-infected TNFRp55 mice. Our results suggest a hitherto underestimated detrimental and pathology-promoting role of T cells in mycobacteria-induced lesions.

The pivotal role of both CD4+ and CD8+ T cells in antimycobacterial protection is well-established and is thought to involve the enhanced production of IFN-{gamma} (6, 9). Regarding M. avium infection, no role was found for CD8+ cells in this respect (9, 25). Granuloma formation in response to M. avium infection proceeds in an accelerated fashion in the presence of CD4+ cells (11, 18); again, CD8+ T cells were demonstrated not to be involved in this process in immunocompetent mice (11, 25).

However, in a disregulated inflammatory response, such as that evident in M. avium-infected TNFRp55-/- mice, both subsets apparently contribute to granuloma disintegration. The cause for the increased presence of both CD4+ and CD8+ T cells in disintegrating granulomatous lesions of TNFRp55-/- mice is not entirely clear. One explanation might be that during the course of infection in TNFRp55+/+ mice, TNFRp55-mediated apoptosis occurs in T cells recruited to or actively dividing in the granuloma. This mechanism would normally regulate the number of T cells present within the lesion, as described in murine autoimmune encephalomyelitis (26). A lack of TNFRp55-mediated T cell apoptosis would result in the enhanced accumulation of T cells, particularly under conditions in which the proliferation of lymphocytes in situ is greatly enhanced, as demonstrated in this study for the lesions in infected TNFRp55-/- mice.

The lethal outcome of M. avium infection in TNFRp55-/- mice investigated in this study is in apparent contrast to another report (10). However, the investigators in that study made use of TNFRp55-/- mice on a 129Sv/BL6 background, which may be assumed to carry the resistant allele of Nramp1. Our own experiments confirmed that genetically resistant TNFRp55-/- mice infected with M. avium do not show granuloma disintegration. Because resistant mice develop only minimal T cell responses to intracellular infections (22, 23), we take this as corroborating evidence that T cells are indeed necessary for the lethal event of granuloma dissolution. Although the inflammatory response in SCID mice is not equivalent to that in immunocompetent mice (18), our experiments in which chronic neutralization of TNF in M. avium-infected SCID mice also did not affect granuloma development tend to further substantiate our interpretation that lethal granuloma disintegration is T cell-dependent.

Most M. avium isolates readily induce IL-12p40 in vitro (27), and we found high levels in the sera of both TNFRp55+/+ and TNFRp55-/- mice. Neutralization of IL-12 led to prolonged survival of M. avium-infected TNFRp55-/- mice, and granulomatous lesions in these mice contained fewer CD3+ cells, specifically fewer CD8+ cells, and did not disintegrate. IL-12 was previously shown to promote lymphocyte recruitment into developing granulomatous lesions (28), and this effect may have critically contributed to lesion development in TNFRp55-/- mice. On the other hand, IL-12p70 is also known to activate Th1 cells (29), and IL-12R interaction in vitro with IL-12p40 homodimer resulted in enhanced Th1 development and increased IFN-{gamma} secretion from CD8+ T cells (30). Moreover, IL-12p40 levels positively correlated with disease activity in multiple sclerosis (31, 32). In line with these reports, we hypothesize that IL-12 is involved in both the recruitment of T cells and their activation within the developing lesion.

The decomposition of granulomas in infected TNFRp55-/- mice always started with conspicuous apoptosis of inflammatory cells within the lesions. Macrophages seemed to be particularly affected, as judged by the frequent presence of mycobacteria within apoptotic cells, although we did not specifically investigate whether other cells, such as T cells or adjacent hepatocytes, also underwent apotosis. However, apoptosis was strikingly absent when T cells were depleted.

Increased numbers of T cells in granulomatous lesions of TNFRp55-/- mice were associated with dramatically higher amounts of IFN-{gamma} in the sera of these mice, and depletion of T cells resulted in reduced IFN-{gamma} levels in the sera of TNFRp55-/- mice. Therefore, one might argue that T cell-derived IFN-{gamma} was the principal inducer of inflammatory cell apoptosis and subsequent tissue necrosis, as was previously shown in the model of gastrointestinal infection with Toxoplasma gondii (33, 34). Although we used, in separate experiments, two different neutralizing mAbs against IFN-{gamma}, both of which had previously been shown to be highly effective in vivo (9, 18), we were unable to demonstrate a role for IFN-{gamma} in granuloma disintegration in infected TNFRp55-/- mice. This finding was corroborated by the results obtained with dexamethasone treatment, which reduced serum IFN-{gamma} in infected TNFRp55-/- mice almost to background levels, but it was ineffective at inhibiting granuloma necrosis. Interestingly, and in contrast to results obtained in the oral infection model with T. gondii in genetically susceptible mice (35), inhibition of iNOS also did not affect the immunopathology observed in TNFRp55-/- mice infected with M. avium.

T cells are known to have the potential for autoreactivity resulting in tissue destruction (36, 37). In experimental models of autoimmune diseases, Fas/Fas ligand (FasL) interactions and membrane TNF-TNFRp75 interactions were described as important mechanisms for the induction of apoptosis by CD4+ cells (38, 39, 40). Cytotoxic T cells were shown to destroy infected target cells via either a Fas/FasL interaction or via a granule-dependent mechanism (41). The exact mechanism by which T cells contribute to inflammatory cell apoptosis and tissue necrosis in infected TNFRp55-/- mice remains to be determined. Because TNF neutralization did not affect M. avium-induced lethality in TNFRp55-/- mice, we consider the TNF/TNFRp75 pathway least likely. However, we cannot formally rule out that signaling through the TNFRp75 did occur in our experiments, because membrane-bound TNF may have been suboptimally affected by our anti-TNF treatment. Whether IL-12, in addition to promoting recruitment of lymphocytes into the developing granuloma (28), also directly up-regulates the expression of Fas/FasL or of the perforin/granzyme system is presently not known.

In conclusion, this study shows that lack of TNFRp55 signaling in the course of M. avium infection results in a hyperinflammatory and ultimately fatal response in which IL-12 promotes the recruitment of T cells, which induce inflammatory cell apoptosis leading to granuloma disintegration. Therefore, TNFRp55-mediated signaling appears to be an integral part of a feedback loop between macrophages and T cells that is normally in place to control and regulate the potentially detrimental T cell-mediated inflammatory response to mycobacterial infection.

The integrity of granulomas is a critical determinant of the outcome of mycobacterial diseases, and apoptosis and necrosis are common events in granulomas associated with human tuberculosis (2, 3, 24, 42, 43). The mycobacteria-infected TNFRp55-/- mouse may prove useful in defining suitable molecular targets for therapeutic interventions aimed at reducing tissue-destroying and life-threatening immunopathology caused by an excess of T cells. Certainly, our findings obtained in gene-deficient mice cannot be directly extrapolated to the immunopathology that occurs in immunocompetent individuals with mycobacterial or other intracellular infections. However, recent results from other experimental infections in TNFRp55-/- mice suggest that the observed absence of adequate lesion control is not unique to infections with a particular pathogen because failure to signal through the TNFRp55 also resulted in failure of lesions to regress once Leishmania major or Rhodococcus equi was eliminated (44). The use of TNFRp55-/- mice has thus not only uncovered a unique role of TNF in the adequate maintenance and resolution of inflammatory lesions, but it also highlights the potentially detrimental and pathology-promoting function of T cells that develops in the course of different types of infections and must be effectively harnessed.


    Acknowledgments
 
We thank Rui Appelberg for providing ascites containing the anti-CD4, anti-CD8, anti-IFN-{gamma}, anti-IL-12p40, and nonspecific control mAbs used in this study, Robert Schreiber for his generous gift of purified anti-TNF mAb, and Johannes Gerdes for his kind gift of the rabbit anti-mouse Ki-67 antiserum.


    Footnotes
 
1 This work was supported in part by grants from the Deutsche Forschungsgemeinschaft to S.E. (SFB 367, C 9) and to K.P. (DFG Pf 259/2–4). Back

2 Address correspondence and reprint requests to Dr. Stefan Ehlers, Division of Molecular Infection Biology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany. Back

3 Abbreviations used in this paper: L-NIL, L-N6-imino-ethyl-lysine; LDH, lactate dehydrogenase; iNOS, inducible form of NO synthase; FasL, Fas ligand; ASAT, alanine serine aminotransferase; Nramp1, natural resistance associated macrophage protein. Back

Received for publication December 22, 1999. Accepted for publication April 13, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kaufmann, S. H. E.. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.[Medline]
  2. Dannenberg, A. M., G. A. W. Rook. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses. , ed. Tuberculosis: Pathogenesis, Protection, and Control 459. Am. Soc. Microbiol. Press, Washington, DC.
  3. Jagirdar, J., D. Zagzag. 1996. Pathology and insights into pathogenesis of tuberculosis. , , ed. Tuberculosis 467. Little, Brown, Boston.
  4. Kindler, V., A.-P. Sappino, G. E. Grau, P.-F. Piguet, P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731.[Medline]
  5. North, R. J., A. A. Izzo. 1993. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection: tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ. Am. J. Pathol. 142:1959.[Abstract]
  6. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, I. M. Orme. 1993. Disseminated tuberculosis in interferon{gamma}-gene-disrupted mice. J. Exp. Med. 178:2243.[Abstract/Free Full Text]
  7. Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504.[Abstract/Free Full Text]
  8. Collins, F. M., R. W. Stokes. 1987. Mycobacterium avium complex infections in normal and immunodeficient mice. Tubercle 68:127.[Medline]
  9. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, P. Minoprio. 1994. Role of {gamma} interferon and tumor necrosis factor {alpha} during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962.[Abstract/Free Full Text]
  10. Doherty, T. M., A. Sher. 1997. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822.[Abstract]
  11. Hänsch, H. C. R., D. A. Smith, M. E. A. Mielke, H. Hahn, G. J. Bancroft, S. Ehlers. 1996. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int. Immunol. 8:1299.[Abstract/Free Full Text]
  12. Benini, J., E. M. Ehlers, S. Ehlers. 1999. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J. Pathol. 189:127.[Medline]
  13. Ehlers, S., J. Benini, S. Kutsch, R. Endres, E. T. Rietschel, K. Pfeffer. 1999. Fatal granuloma necrosis despite intact antibacterial functions in TNFRp55-gene-deficient mice chronically infected with M. avium. Infect. Immun. 67:3571.[Abstract/Free Full Text]
  14. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Ahahinian, K. Wiegmann, P. S. Ohashi, M. Krönke, T. W. Mak. 1993. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.[Medline]
  15. Rothe, J., W. Leslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.[Medline]
  16. Kosco-Vilbois, M. H., H. Zentgraf, J. Gerdes, J. Y. Bonnefoy. 1997. To "B" or not to "B" a germinal center?. Immunol. Today 18:225.[Medline]
  17. Mielke, M. E. A., S. Ehlers, H. Hahn. 1988. T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2 cells in acquired immunity. Infect. Immun. 56:1920.[Abstract/Free Full Text]
  18. Smith, D. A., H. C. R. Hänsch, G. J. Bancroft, S. Ehlers. 1997. T cell independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-{alpha} and interferon-{gamma}. Immunology 92:413.[Medline]
  19. Castro, A. G., R. A. Silva, R. Appelberg. 1995. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. Immunology 155:2013.
  20. Stenger, S., H. Thüring, M. Röllinghoff, P. Manning, C. Bogdan. 1995. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. Eur. J. Pharmacol. 294:703.[Medline]
  21. Ehlers, S., S. Kutsch, J. Benini, A. Cooper, C. Hahn, J. Gerdes, I. M. Orme, C. Martin, E. T. Rietschel. 1999. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in M. avium-infected mice without affecting bacterial loads. Immunology 98:313.[Medline]
  22. Vidal, S., P. Gros, E. Skamene. 1995. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukocyte Biol. 58:382.[Abstract]
  23. Stokes, R. W., F. M. Collins. 1990. Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice. Clin. Exp. Immunol. 89:109.
  24. Rook, G. A. W., B. R. Bloom. 1994. Mechanisms of pathogenesis of tuberculosis. , ed. Tuberculosis: Pathogenesis, Protection, and Control 485. Am. Soc. Microbiol. Press, Washington, DC.
  25. Bermudez, L. E., M. Petrofsky. 1999. Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells. Infect. Immun. 67:3108.[Abstract/Free Full Text]
  26. Bachmann, R., H. P. Eugster, K. Frei, A. Fontana, H. Lassmann. 1999. Impairment of TNF-receptor-1 signalling but not FAS signalling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am. J. Pathol. 154:1417.[Abstract/Free Full Text]
  27. von Grünberg, P. W., G. Plum. 1998. Enhanced induction of interleukin-12p40 secretion by human macrophages infected with Mycobacterium avium complex isolates from disseminated infection in AIDS patients. J. Infect. Dis. 178:1209.[Medline]
  28. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.[Medline]
  29. Trinchieri, G.. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83.[Medline]
  30. Piccotti, J. R., S. Y. Chan, K. Li, E. J. Eichwald, D. K. Bishop. 1997. Differential effects of IL-12 receptor blockade with IL-12p40 homodimer on the induction of CD4+ and CD8+ IFN-{gamma}-producing cells. J. Immunol. 158:643.[Abstract]
  31. Fassbender, K., A. Ragoschke, S. Rossol, A. Schwartz, O. Mielke, A. Paulig, M. Hennerici. 1998. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 51:753.[Abstract/Free Full Text]
  32. van Boxel-Dezaire, A. H., S. C. Hoff, B. W. van Oosten, C. L. Verweij, A. M. Drager, H. J. Ader, J. C. van Houwelingen, F. Barkhof, C. H. Polman, L. Nagelkerken. 1999. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45:695.[Medline]
  33. Liesenfeld, O., J. C. Kosek, J. S. Remington, Y. Suzuki. 1996. Association of CD4+ T cell-dependent, interferon-{gamma}-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:597.[Abstract/Free Full Text]
  34. Liesenfeld, O., J. C. Kosek, Y. Suzuki. 1997. {gamma} Interferon induces Fas-dependent apoptosis of Peyer’s patch T cells in mice following peroral infection with Toxoplasma gondii. Infect. Immun. 65:4682.[Abstract]
  35. Liesenfeld, O., H. Kang, D. Park, T. A. Nguyen, C. V. Parkhe, H. Watanabe, T. Abo, A. Sher, J. S. Remington, Y. Suzuki. 1999. TNF-{alpha}, nitric oxide and IFN-{gamma} are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol. 21:365.[Medline]
  36. Yoon, J. W., H. S. Jun, P. Santamaria. 1998. Cellular and molecular mechanisms for the initiation and progression of ß cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27:109.[Medline]
  37. Gran, B., B. Hemmer, M. Vergelli, H. F. McFarland, R. Martin. 1999. Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann. Neurol. 45:559.[Medline]
  38. Siegel, R. M., T. A. Fleisher. 1999. The role of Fas and related death receptors in autoimmune and other disease states. J. Allergy Clin. Immunol. 103:729.[Medline]
  39. Douni, E., G. Kollias. 1998. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin {alpha}, or the p55 TNF-R. J. Exp. Med. 188:1343.[Abstract/Free Full Text]
  40. Kusters, S., G. Tiegs, L. Alexopoulou, M. Pasparakis, E. Douni, G. Kunstle, H. Bluethmann, A. Wendel, K. Pfizenmaier, G. Kollias, M. Grell. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27:2870.[Medline]
  41. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, R. L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.[Abstract/Free Full Text]
  42. Placido, R., G. Mancino, A. Amendola, F. Mariani, S. Vendetti, M. Piacentini, A. Sanduzzi, M. L. Bocchino, M. Zembala, V. Colizzi. 1997. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J. Pathol. 181:31.[Medline]
  43. Cree, I. A., S. Nurbhai, G. Milne, J. S. Beck. 1987. Cell death in granulomata: the role of apoptosis. J. Clin. Pathol. 40:1314.[Abstract/Free Full Text]
  44. Kanaly, S. T., M. Nashleanas, B. Hondowicz, P. Scott. 1999. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J. Immunol. 163:3883.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Schaefer, N. Reiling, C. Fessler, J. Stephani, I. Taniuchi, F. Hatam, A. O. Yildirim, H. Fehrenbach, K. Walter, J. Ruland, et al.
Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection
J. Immunol., May 15, 2008; 180(10): 6836 - 6845.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
S. Tsiodras, G. Samonis, D. T. Boumpas, and D. P. Kontoyiannis
Fungal Infections Complicating Tumor Necrosis Factor {alpha} Blockade Therapy
Mayo Clin. Proc., February 1, 2008; 83(2): 181 - 194.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Rottman, E. Catherinot, P. Hochedez, J.-F. Emile, J.-L. Casanova, J.-L. Gaillard, and C. Soudais
Importance of T Cells, Gamma Interferon, and Tumor Necrosis Factor in Immune Control of the Rapid Grower Mycobacterium abscessus in C57BL/6 Mice
Infect. Immun., December 1, 2007; 75(12): 5898 - 5907.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Florido and R. Appelberg
Characterization of the Deregulated Immune Activation Occurring at Late Stages of Mycobacterial Infection in TNF-Deficient Mice
J. Immunol., December 1, 2007; 179(11): 7702 - 7708.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Cowley, J. D. Sedgwick, and K. L. Elkins
Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth
J. Immunol., December 1, 2007; 179(11): 7709 - 7719.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. V. Kondratieva, V. V. Evstifeev, T. K. Kondratieva, S. N. Petrovskaya, A. V. Pichugin, E. I. Rubakova, M. M. Averbakh Jr., and A. S. Apt
I/St Mice Hypersusceptible to Mycobacterium tuberculosis Are Resistant to M. avium
Infect. Immun., October 1, 2007; 75(10): 4762 - 4768.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Musicki, H. Briscoe, S. Tran, W. J. Britton, and B. M. Saunders
Differential Requirements for Soluble and Transmembrane Tumor Necrosis Factor in the Immunological Control of Primary and Secondary Listeria monocytogenes Infection.
Infect. Immun., June 1, 2006; 74(6): 3180 - 3189.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Zakharova and H. K. Ziegler
Paradoxical Anti-Inflammatory Actions of TNF-{alpha}: Inhibition of IL-12 and IL-23 via TNF Receptor 1 in Macrophages and Dendritic Cells
J. Immunol., October 15, 2005; 175(8): 5024 - 5033.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. M. Saunders, S. Tran, S. Ruuls, J. D. Sedgwick, H. Briscoe, and W. J. Britton
Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection
J. Immunol., April 15, 2005; 174(8): 4852 - 4859.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
V. Rao, N. Fujiwara, S. A. Porcelli, and M. S. Glickman
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule
J. Exp. Med., February 22, 2005; 201(4): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. T. Giles and J. M. Bathon
Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases
J Intensive Care Med, November 1, 2004; 19(6): 320 - 334.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
M. Florido and R. Appelberg
Granuloma Necrosis during Mycobacterium avium Infection Does Not Require Tumor Necrosis Factor
Infect. Immun., October 1, 2004; 72(10): 6139 - 6141.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. M. S. Algood, P. L. Lin, D. Yankura, A. Jones, J. Chan, and J. L. Flynn
TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection
J. Immunol., June 1, 2004; 172(11): 6846 - 6857.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. M. Coussens, N. Verman, M. A. Coussens, M. D. Elftman, and A. M. McNulty
Cytokine Gene Expression in Peripheral Blood Mononuclear Cells and Tissues of Cattle Infected with Mycobacterium avium subsp. paratuberculosis: Evidence for an Inherent Proinflammatory Gene Expression Pattern
Infect. Immun., March 1, 2004; 72(3): 1409 - 1422.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S Ehlers
Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF
Ann Rheum Dis, November 1, 2003; 62(90002): ii37 - 42.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
T. D. Nguyen, G. Bigaignon, D. Markine-Goriaynoff, H. Heremans, T. N. Nguyen, G. Warnier, M. Delmee, M. Warny, S. F. Wolf, C. Uyttenhove, et al.
Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and {gamma}-interferon
J. Med. Microbiol., October 1, 2003; 52(10): 869 - 876.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Villarreal-Ramos, M. McAulay, V. Chance, M. Martin, J. Morgan, and C. J. Howard
Investigation of the Role of CD8+ T Cells in Bovine Tuberculosis In Vivo
Infect. Immun., August 1, 2003; 71(8): 4297 - 4303.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K.-i. Inoue, H. Takano, R. Yanagisawa, T. Yoshikawa, R. Vassallo, E. L. Matteson, and C. F. Thomas Jr.
Effects of Tumor Necrosis Factor-{alpha} Inhibitors on Lung Lesions With Rheumatoid Arthritis
Chest, July 1, 2003; 124(1): 413 - 414.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. C. Taylor, R. Orkin, and J. Lanham
Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy
Rheumatology, July 1, 2003; 42(7): 901 - 902.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ehlers, C. Holscher, S. Scheu, C. Tertilt, T. Hehlgans, J. Suwinski, R. Endres, and K. Pfeffer
The Lymphotoxin {beta} Receptor Is Critically Involved in Controlling Infections with the Intracellular Pathogens Mycobacterium tuberculosis and Listeria monocytogenes
J. Immunol., May 15, 2003; 170(10): 5210 - 5218.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Ehlers, J. Benini, H.-D. Held, C. Roeck, G. Alber, and S. Uhlig
{alpha}{beta} T Cell Receptor-positive Cells and Interferon-{gamma}, but not Inducible Nitric Oxide Synthase, Are Critical for Granuloma Necrosis in a Mouse Model of Mycobacteria-induced Pulmonary Immunopathology
J. Exp. Med., December 17, 2001; 194(12): 1847 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. G. Mansfield, R. S. Veazey, A. Hancock, A. Carville, M. Elliott, K.-C. Lin, and A. A. Lackner
Induction of Disseminated Mycobacterium avium in Simian AIDS Is Dependent upon Simian Immunodeficiency Virus Strain and Defective Granuloma Formation
Am. J. Pathol., August 1, 2001; 159(2): 693 - 702.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. Chen, Y. Wei, G. C. Sharp, and H. Braley-Mullen
Induction of Experimental Autoimmune Thyroiditis in IL-12-/- Mice
J. Immunol., August 1, 2001; 167(3): 1720 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
W. F. Dietrich
Using Mouse Genetics to Understand Infectious Disease Pathogenesis
Genome Res., March 1, 2001; 11(3): 325 - 331.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehlers, S.
Right arrow Articles by Pfeffer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehlers, S.
Right arrow Articles by Pfeffer, K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Tuberculosis


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS